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INTRODUCTION: Sarcomatoid Carcinoma (SC) is a 
rare malignant tumor characterized by both 
sarcomatous and carcinomatous features. Despite an 
epithelial origin, the tumor contains a combination of 
both epithelial and mesenchymal components1. Found 
in various organs, this malignancy comprises about 1% 
of all lung neoplasms It can appear centrally or 
peripherally in the lungs but is more commonly found 
as a peripheral solitary mass with an affinity for the 
upper lobes2,3. Smoking, alcohol use, previous history 
of radiation therapy and asbestos exposure are some of 
the established risk factors of this condition 4,5. The 
disease is four times more commonly found in men 
than women. The average age of diagnosis ranges 
between 65 to 75 years6. Though it has a variable 
clinical presentation, some typical symptoms of 
pulmonary SC include chest pain, cough, dyspnea and 
fever7. It is important to distinguish this tumor from 
other mesenchymal neoplasms due to its aggressive 
nature, poor prognosis and extensive metastasis. 
Majority of cases are diagnosed at a later stage when 
there is multiple metastasis.We present a rare case of 
a patient with Pulmonary Sarcomatoid Carcinoma with 
left atrial involvement and spinal metastasis who 
presented with an ischemic infarct of the left basal 
ganglia. Pulmonary Sarcomatoid Carcinomas represent 
0.2-1% of all lung cancers. We report the first case of 
female patient non-smoker with pulmonary 
sarcomatoid carcinoma with left atrial involvement and 
spinal metastasis who presented with ischemic infarct 
from Pakistan.
Case report:
36-year-old Asian lady without any prior known 
comorbids presented to the emergency department 
with right sided body weakness and numbness with 
associated slurred speech for one day.During the last 1 
week she had shown recurrent episodes of 
paresthesias and numbness in right upper and lower 
extremity. In between these episodes, patient was back 
to normal without any residual symptoms. On 
examination, she had a blood pressure of 110/70 mm 
Hg, a heart rate of 80bpm, a temperature of 370C, and 
a respiratory rate of 18 breaths per minute. On 
neurological exam she was awake alert and oriented. 
She had weakness in right arm with power of 4/5, chest 
and cardiac examination was normal . ECG showed 
normal sinus rhythm. Baseline laboratory investigations 
were within normal limits. 3 months prior to admission 
she had  dry cough, progressive exertional dyspnea and 
palpitations for which workup was done her chest X-ray 
done in January 2019 showing right upper lobe 
consolidation, followed by CT chest in February 2019, 
which revealed irregular, partially enchaining hyper 
abuse. By the time that she presented to the hospital, 
the tumor had metastasized to the C3- C5 vertebral 
levels. A previous case report has documented SC 
metastasis from the lung to the T8 vertebrae of a 
63-year-old male who was a chronic smoker that 
presented with back pain10. the tumor was causing 
severe spinal stenosis. In our case the tumor had not 
impinged deeply enough to cause severe spinal 
stenosis. However, the cancer itself is quite uncommon 
and such a presentation with spinal metastasis with  no 
symptoms of pain ‘tingling or numbness. 
Embolization to the central nervous system may result 
in transient ischemic attack, stroke, or seizure. Strokes 
are often recurrent  and embolic and abrupt14. 
Cardiogenic emboli account for 15–30% of ischemic 
strokes5. 
Hypercoagulability in malignancy is common as the 
coagulation cascade is activated by tumor cells, 
resulting in venous thrombosis in distant sites10,11.
The ability of malignant cells to interact with the blood 
cells of the hemostatic system (endothelial cells, 
platelets, and monocytes etc.), induce procoagulants 
and inflammatory cytokines contribute to the 
pathogenesis of a stroke in these patients14.
D-dimer, a degraded product of fibrin polymer, is a 
useful indicator of hypercoagulability, which frequently 
increases in cancer-associated stroke. Multiple embolic 
strokes with elevated D-dimer alert the possibility of 
occult cancer. Malignancy-associated thrombosis tends 
to follow an anatomic pattern of involvement and 
includes large artery bifurcations, and small vessel 
disease are common stroke mechanisms12,13.In our 
patient D-dimer was normal.
The embolic showering occurs when tumor fragments 
are sheared and enter the body's circulation, resulting 
in either embolic occlusion or metastatic seeding at 
distant sites 16,17. The incidence of lung cancer with 
atrial extensions that progress to showering emboli is 
unclear. 
Due to poor prognosis and limited life expectancy. , a 
multidisciplinary approach is necessary to address the 
physical, emotional, and spiritual needs of the patient 
and family   regarding end of life and goals of care. 
There is no clear evidence that chemotherapy prolongs 
survival.
Conclusion:
An atypical presentation and lack of concrete risk 
factors in certain patients continues to make 
pulmonary sarcomatoid carcinoma a diagnostic 
challenge. Although tumor emboli to cerebral are rare 
but the possibility should be considered in differential 
diagnosis of stroke  when dealing with patients who give 
off the slightest suspicion of malignancy as earlier 
diagnosis will lead to a better patient outcome.
A RARE PRESENTATION OF PULMONARY SARCOMATOID
CARCINOMA WITH LEFT ATRIAL INVOLVEMENT AND
SPINAL METASTASIS PRESENTING WITH AN ISCHEMIC
INFARCT.
P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S 2 6
dense heterogenous soft tissue mass in right hilar 
region (6x2 cm) causing pressure effect to adjacent 
structures encasing right bronchus. Multiple small 
round nodules were noted in both lungs. On 
echocardiogram multiple echogenic masses in left 
atrium were noted with largest echogenic mass (4x6 
cm) in occupying 80% space with extension to the 
mitral valve leaflet anteriorly causing obstructive flow. 
She had   no history of tobacco, alcohol or use of 
recreational drugs  no history of weight loss. Strong 
family history of malignancy in grandparents (breast 
and uterine) and uncle (prostate carcinoma) was 
present. She had past history of leiyomyoma and 
myomectomy was done  in 2016. Based on history and 
relevant investigations, an initial impression of a 
possible left sub-cortical infarct, with possibility of 
involvement of lung mass was made and brain imaging 
with contrast was ordered with workup for malignancy. 
Magnetic resonance imaging (MRI) of the brain with 
gadolinium contrast revealed.  Acute left basal ganglia 
infarct.Middle cerebral arteries to be patent and normal 
in calibre.Magnetic resonance angiography(MRA) and 
magnetic resonance venography (MRV) were normal.
Figure 1 A and B showed Left basal ganglion 
infarct with diffusion restriction and ADC drop out.
Cervical MRI with contrast was done which showed left 
paravertebral soft tissue lesion extending from C3 to C5 
vertebral levels, these lesions were suggestive of 
metastatic origin.
 C.T chest with contrast was repeated later also which 
was suggestive of large heterogeneous right upper lobe 
neoplastic mass lesion, measuring approximately 99 x 
83 x 139 mm in AP, transverse and craniocaudal 
dimensions associated with thrombus in pulmonary 
vein   extending up to the left atrium, likely representing 
tumor thrombus in left atrium  and multiple bilateral 
pulmonary metastatic deposits . 
C.T guided biopsy of right upper lobe mass showed 
sarcomatoid carcinoma, suggestive of either 
metastasis from sarcomatoid   carcinoma of primary 
lung origin. In setting of  left atrial invasion and thrombo 
emboli spread to brain the patient was starts 
anticoagulation her neurological status improved and 
she was transferred to oncology for chemotherapy.
Figure 2 showing Abnormal signal with 
enhancement involving C4 vertebral body with 
associated left paravertebral soft tissue lesion 
extending from C3 to C5 vertebral levels.
Figure 3 A large heterogenously enhancing soft 
tissue mass lesion in right  upper hemithorax 
arising from right lung
Discussion 
The World Health Organization has defined Pulmonary 
Sarcomatoid Carcinomas as ‘poorly differentiated 
non-small cell lung carcinomas (NSCLCs) containing a 
sarcoma-like element (malignant spindle or giant cells) 
or sarcomatous component’. Based on this definition, 
these tumors have been further classified into 5 types 
called pleomorphic carcinoma, giant cell carcinoma, 
carcinosarcoma, spindle cell carcinoma and pulmonary 
blastoma8. These tumors are diagnosed based on their 
characteristic morphological appearance on light 
microscopy. Immunohistochemistry acts as an 
adjunctive diagnostic tool to help rule out other 
morphologically similar lesions.
A, confirming the diagnosis of pleomorphic carcinoma. 
Studies have shown that using cytokeratin AE1/AE3 is 
usually enough to support the diagnosis of pulmonary 
SC9. TTF-1 and Napsin have also been implicated in the 
diagnosis of SC.
Typically, pulmonary SC patients are elderly males with 
a chronic history of smoking. Our patient did not have 
the usual risk factors of pulmonary SC.  She was 45 
years of age, 20 years younger than the mean age of 
diagnosis and had no history of smoking or alcohol 
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ABSTRACT:
Pulmonary Sarcomatoid Carcinoma is a rare, aggressive tumor comprising of both epithelial and mesenchymal cells. 
It is important to distinguish it from other lung tumors due to its poor prognosis and extensive metastasis. We present 
a case of a 36 year old female patient who initially presented with right sided weakness and slurred speech due to an 
ischemic infarct of the left basal ganglia. Further workup revealed a lung mass extending to the left atrium with spinal 
metastasis. Sarcomatoid Carcinoma remains a diagnostic challenge due to its  early recurrence and atypical 
presentation. 
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distant sites 16,17. The incidence of lung cancer with 
atrial extensions that progress to showering emboli is 
unclear. 
Due to poor prognosis and limited life expectancy. , a 
multidisciplinary approach is necessary to address the 
physical, emotional, and spiritual needs of the patient 
and family   regarding end of life and goals of care. 
There is no clear evidence that chemotherapy prolongs 
survival.
Conclusion:
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diagnosis of stroke  when dealing with patients who give 
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